Medicare Enrolled

Dr. Ira Epstein, DO

Nephrology · North Richland Hills, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
6331 BOULEVARD 26, North Richland Hills, TX 76180
8176280284
Registered in NPPES since 2006
NPI: 1205886207 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Epstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Epstein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Epstein

Dr. Ira Epstein is a nephrology specialist in North Richland Hills, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Epstein performed 893 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Epstein received a total of $9,897 from 43 pharmaceutical and/or device companies across 468 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Epstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 893 Medicare services $9,897 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
893
Medicare services
Bottom 39% in TX for nephrology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$129
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
399 $71 $256
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
197 $249 $706
Home dialysis services per month
Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older.
98 $209 $586
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
72 $6 $6
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
68 $96 $360
New patient office visit, complex (60-74 min) 32 $151 $442
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
27 $194 $588
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,897
Total received (2018-2024)
Avg $1,414/year across 7 years
Top 10% in TX for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
468
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,302
2023
$2,042
2022
$2,003
2021
$1,166
2020
$809
2019
$980
2018
$594

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$480
Mallinckrodt Hospital Products Inc.
$369
Boehringer Ingelheim Pharmaceuticals, Inc.
$261
OPKO Pharmaceuticals, LLC
$215
Bayer Healthcare Pharmaceuticals Inc.
$142
Amgen Inc.
$135
Ardelyx, Inc.
$115
Novartis Pharmaceuticals Corporation
$87
Otsuka America Pharmaceutical, Inc.
$87
SHIELD THERAPEUTICS INC
$82
Fresenius USA Marketing, Inc.
$71
CALLIDITAS THERAPEUTICS US INC.
$66
Novo Nordisk Inc
$62
Vifor Pharma, Inc.
$49
Daiichi Sankyo Inc.
$25
CorMedix Inc.
$23
Travere Therapeutics, Inc.
$19
Lilly USA, LLC
$14
Top 3 companies account for 48.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,175
Otsuka America Pharmaceutical, Inc.
$915
Mallinckrodt Hospital Products Inc.
$763
OPKO Pharmaceuticals, LLC
$751
Bayer HealthCare Pharmaceuticals Inc.
$716
Amgen Inc.
$619
Vifor Pharma, Inc.
$542
Fresenius USA Marketing, Inc.
$446
Bayer Healthcare Pharmaceuticals Inc.
$365
Boehringer Ingelheim Pharmaceuticals, Inc.
$340
Horizon Therapeutics plc
$333
Daiichi Sankyo Inc.
$312
Travere Therapeutics, Inc.
$258
Exeltis, USA Inc.
$223
GlaxoSmithKline, LLC.
$201
Relypsa, Inc.
$195
Calliditas Therapeutics US Inc.
$175
Ardelyx, Inc.
$144
Mallinckrodt Enterprises LLC
$139
Novartis Pharmaceuticals Corporation
$124
Amicus Therapeutics, Inc.
$116
Mallinckrodt LLC
$107
Novo Nordisk Inc
$107
AKEBIA THERAPEUTICS INC
$97
CALLIDITAS THERAPEUTICS US INC.
$88
Takeda Pharmaceuticals U.S.A., Inc.
$83
SHIELD THERAPEUTICS INC
$82
GENZYME CORPORATION
$78
Aurinia Pharma U.S., Inc.
$71
Lilly USA, LLC
$65
ANI Pharmaceuticals, Inc.
$54
Pharmacosmos Therapeutics Inc.
$24
Alexion Pharmaceuticals, Inc.
$24
CorMedix Inc.
$23
Retrophin, Inc.
$22
PFIZER INC.
$20
Medtronic, Inc.
$17
Horizon Pharma plc
$16
Bard Peripheral Vascular, Inc.
$16
Baxter Healthcare
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
Keryx Biopharmaceuticals, Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 28.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ACCRUFER · ACTHAR · AURYXIA · Aranesp · Auryxia · BENLYSTA · CYCLOSET · DefenCath · ELIQUIS · ELLIPSYS VASCULAR ACCESS SYSTEM · ENTRESTO · EPOGEN · Edarbyclor · FABRAZYME · FARXIGA · GALAFOLD · IBSRELA · INJECTAFER · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · MOUNJARO · Monoferric · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Renal - PD · Rybelsus · SAMSCA · TARPEYO · TAVNEOS · TRULICITY · Uloric · Ultomiris · Velphoro · Veltassa
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nephrology specialist in North Richland Hills?
Compare nephrologists in the North Richland Hills area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists in nearby ZIP areas
148
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY NORTH HILLS
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Epstein is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Epstein experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Epstein performed 399 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Epstein receive payments from pharmaceutical companies?
Yes. Dr. Epstein received a total of $9,897 from 43 companies across 468 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Epstein's costs compare to other nephrologists in North Richland Hills?
Dr. Epstein's average Medicare payment per service is $129. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Epstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →